US Vaccine Policy Shift Sparks Health Care Decline

Monday, Jan 5, 2026 7:02 pm ET1min read

Healthcare companies declined as traders evaluated changes to vaccine rules. The US will drop universal recommendations for certain childhood vaccines, marking a significant shift in vaccine policy. Sanofi's Tzield type-1 diabetes drug is under FDA review for expansion to children as young as one year old. Novo Nordisk shares rose after its Wegovy weight-loss pill became widely available in the US, while Eli Lilly shares fell.

US Vaccine Policy Shift Sparks Health Care Decline

Comments



Add a public comment...
No comments

No comments yet